First Announcement

28 Years
1983  -  Hamburger Symposia on Tumor Markers  -  2011
Tumor Associated Substances in Tumor Diagnosis and Tumor Therapy

Hamburger Symposium About Tumormarker


International Workshop
May 29-31, 2011


Research, Actual State and Trends in Tumor Diagnosis and Therapy

Location
Hotel Grand Elysee - Hamburg
Rothenbaumchaussee 10
20148 Hamburg
Telefon
+49 40 414 12-0
Fax
+49 40 414 12-733
eMail
elysee-hamburg@t-online.de
Internet
www.elysee-hamburg.de

Chairman
Prof. Dr. R. Klapdor
Hamburger Symposien über Tumormarker

Bergstraße 14, 20095 Hamburg
Telefon
+49 40 309 55-19
Fax
+49 40 309 55-28

Rothenbaumchaussee 5, 20148 Hamburg
Telefon
+49 40 410 2558
Fax
+49 40 410 2568
eMail
Prof.Klapdor@t-online.de
Internet
www.hstm.de

Organization
Hamburger Symposien über Tumormarker and ZeTDT GmbH (Centre for clinical and experimental Tumormarker Diagnosis and Therapy) in cooperation with the UCCH (University Cancer Center Hamburg, Hubertus Wald Tumorzentrum), supported by the EGTM (European Group on Tumor Markers).



Official Languages
English / German
Simultaneous translation

Scientific Advisory Board
Prof. Dr. D. Arnold, Hamburg, Germany
Prof. Dr. V. Barak, Jerusalem, Israel
Prof. Dr. C. Bokemeyer, Hamburg, Germany
Dr. J.M.G. Bonfrer, Amsterdam, The Netherlands
Dr. J. Delinassios, Athens, Greece
Prof. Dr. M. Dietel, Berlin, Germany
Dr. A. A. Epenetos, London, UK
Dr. C. Fenner, Hamburg, Germany
Dr. C. Haglund, Helsinki, Finland
Prof. Dr. I. R. Izbicki, Hamburg, Germany
Prof. Dr. R. Klapdor, Hamburg, Germany
Prof. Dr. R. Lamerz, Munich, Germany
Dr. P. Molina, Barcelona, Spain
Prof. Dr. W. Müller-Ruchholtz, Kiel, Germany
Dr. M. Nap, Heerlen, The Netherlands
Prof. K. Pantel, Hamburg, Germany
Prof. Dr. G. Sauter, Hamburg, Germany
Dr. P. Stieber, Munich, Germany
Dr. C. Sturgeon, Edinburgh, UK
Prof. Dr. O. Topolcan, Pilsen, Czech Republic
Dr. G.C. Torre, Albenga, Italy
Prof. Dr. A. Semjonow, Münster, Germany

Main Topics
Tumor related substances (Tumor markers, oncogenes, receptors)
- in vitro diagnosis
- in vivo diagnosis
- immunhistology / immuncytology
- Tumordiagnosis
- Tumortherapy

State and trends in immunotherapy
Gentherapy – state and potential possibilities
Molecular screening and role for tumor therapy
Net work structures regarding care and clinical research
New targeted treatment strategies
Metabolic tumor control
Pretherapeutical sensitivity tests

Self-help-organizations: Acitivites and  potential role in clinical oncology and care of tumor patients

Satellite Symposium:
Tumor diseases of the pancreas - actual state and trends in diagnosis and therapy.

Publication
The Abstracts will be published in a supplement of "Anticancer Research" and will be available at the Congress.

The full manuscripts of the presentation will be published as Proceedings of the Congress in a further supplement of "Anticancer Research" in the year 2011 or in early  2012. To assure early publication, the full manuscripts have to be submitted for publication at the Congress (Microsoft Word format preferred), before their presentation.


Industrial Exhibition
An exhibition of the leading industries in tumor diagnosis and tumor therapy is being arranged during the Congress. It will be open from May 29-31, during the meeting hours of the Congress. For further information please contact the Congress Organization.

Poster Awards
A committee of the "Scientific Advisory Board" will again select each day of the scientific programm two poster presentations for Poster Awards combined with a cheque of 500 Euro and 250 Euro respectively. The Awards will be distributed at the end of the daily scientific programms.

Submission of abstracts

By mail until March 20, 2011,
by email until March 30, 2011 - latest until April 10, 2011

Registration fee
160,00 Euro active participants (inclusive Abstract Book and proceedings)

MTA and Students
50,00 Euro (incl. Abstract Book)

Bank account
ZeTDT GmbH, HASPA 1238 160335, BLZ 20050550
Use: Separate account: 15th HSTM, Prof. Klapdor
IBAN: DE42 20050550 1238 160 335
BIC/SWIFT: HASPDEHHXXX



The symposium is kindly supported by leading companies on the field of tumor diagnosis and therapy.


Location plan: